Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from SeaStar Medical Holding ( (ICU) ) is now available.
On August 13, 2025, SeaStar Medical Holding Corporation’s Board of Directors terminated the employment of David Green, the Chief Financial Officer and Treasurer, effective August 14, 2025. The termination was without cause, and the company plans to provide Mr. Green with a severance package, including a continued base salary and accelerated stock vesting. Subsequently, on August 19, 2025, the Board appointed Eric Schlorff, the CEO, as the interim CFO and Treasurer, and Bradford Towne as the principal accounting officer, as the company searches for a permanent CFO.
The most recent analyst rating on (ICU) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on SeaStar Medical Holding stock, see the ICU Stock Forecast page.
Spark’s Take on ICU Stock
According to Spark, TipRanks’ AI Analyst, ICU is a Underperform.
SeaStar Medical Holding faces significant financial challenges, with negative equity and reliance on external financing posing risks to its financial health. Technical indicators show bearish momentum, and valuation metrics highlight ongoing losses, contributing to a low overall stock score.
To see Spark’s full report on ICU stock, click here.
More about SeaStar Medical Holding
Average Trading Volume: 7,698,592
Technical Sentiment Signal: Sell
Current Market Cap: $22.44M
For a thorough assessment of ICU stock, go to TipRanks’ Stock Analysis page.